LTR Pharma’s plans to raise capital via institutional placement were featured in the Financial Review following the Company’s trading halt on Friday.
Here’s an excerpt:
“Nasal viagra biotech LTR Pharma, whose shares have risen 176 per cent over the past 12 months, was seeking to raise $20 million on Friday via an institutional placement.
LTR shares were offered at 92¢ apiece, which represented a 21.6 per cent discount to the 10-day volume-weighted average price. The stock last changed hands at $1.05.”